NGS testing in clinical practice - what to expect
We help laboratories focus on what matters most to patients – correct and fast diagnosis every time. Our genetic test kits with integrated software set new standards in DNA diagnostic testing.
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Complete sequencing of the CFTR gene to detect all mutations. Learn more
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Rapid diagnosis of prenatal aneuploidies and male infertility. Learn more
Targeted cancer gene sequencing to identify clinically significant variants. Learn more
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden
News | December 1, 2022
New chimerism software for your improved workflow -speed, usability, and customizable reports
Time is precious. Every minute, every second that we can simplify your lab’s workflow shortens the...Find out moreFind out more
News | November 17, 2022NGS for thalassemia genetic testing – insights from a customer implementation journey
News | November 10, 2022Devyser Diagnostics AB publishes Interim Report for the period, January to September 2022
News | November 9, 2022Devyser strengthens its presence on the US market - establishes proprietary CLIA lab
Thalassemia is typically caused by sequence variants in the HBA1, HBA2 or HBB genes. The common...
Thalassemia is an inherited blood disorder with a worldwide prevalence of nearly 300,000 per year....
Alpha- and beta-thalassemia are distinct hematologic disorders caused by a defect in globin chain...